Tohoku J. Exp. Med., 2012 Nov, 228(3)

Production of Nitric Oxide Is Lower in Shiga Toxin-Stimulated Neutrophils of Infants Compared to Those of Children or Adults

SHOJI TSUJI,1 ANNA IHARADA,1 TAKAHISA KIMATA,1 TOMOHIKO SHIMO,1 MASATO HIRABAYASHI1 and KAZUNARI KANEKO1

1Department of Pediatrics, Kansai Medical University, Osaka, Japan

Hemolytic uremic syndrome (HUS) in infants is mainly caused by the Shiga toxin (Stx), which is produced by pathogenic Escherichia coli O157:H7. Infants are prone to develop HUS in comparison to older children and adults, but its underlying mechanism remains unknown. Recent observations suggest that reactive oxygen species (ROS) and reactive nitrogen species (RNS) including nitric oxide (NO) may be involved in the pathogenesis of HUS. We therefore measured NO production by neutrophils prepared from infants (6-27 months old), children (5.3-11 years old) or adults (25-47 years old). The NO production was measured by a flow cytometric analysis with a fluorescent indicator (expressed as mean fluorescence intensity), and mRNA expression of inducible NO synthase (iNOS) was analyzed by reverse transcription-polymerase chain reaction (RT-PCR). The amount of NO produced was significantly lower in Stx-stimulated neutrophils prepared from infants (45.8 ± 23.3) than that in those from children (120.5 ± 81.5) or adults (127.7 ± 45.8) (n = 10 each group, P < 0.05). The expression level of iNOS mRNA was lower in Stx-stimulated neutrophils of the infants than the level in those of children or adults. In conclusion, Stx increased NO production in neutrophils probably via iNOS. Importantly, the degree of the Stx-mediated increase in NO production was lower in neutrophils of infants compared to those of children or adults, which may explain the higher incidence of HUS in infants. These results suggest that NO may contribute to the cellular defense mechanisms against Stx.

keywords —— hemolytic uremic syndrome; neutrophils; nitric oxide; reactive oxygen species; Shiga toxin

===============================

Tohoku J. Exp. Med., 2012, 228, 247-252

Correspondence: Shoji Tsuji, M.D., Ph.D., Department of Pediatrics, Kansai Medical University, 2-3-1 Shin-machi, Hirakata, Osaka 573 1191, Japan.

e-mail: tsujis@hirakata.kmu.ac.jp